News dal mondo
04
Mar
ECHA’s Risk Assessment Committee adopts its opinion on PFAS restriction proposal
The European Chemicals Agency’s (ECHA) Risk Assessment Committee (RAC) has concluded its evaluation of the universal restriction proposal on all per- and polyfluoroalkyl substances (PFAS). Its opinion is the first part of ECHA’s two-committee scientific evaluation of the proposal...[ECHA]
28
Apr
Sun Pharma compra Organon
Sun Pharmaceutical Industries ha firmato un accordo definitivo per acquisire Organon &...
27
US QMM: Participants scored well on commitment to quality, lower on advanced manufacturing
Pharmaceutical companies participating in the US Food and Drug Administration (FDA) Quality Maturity...
23
Top Drugs at Risk of Supply Shortages
Nearly half of 100 vulnerable medicines have at least one key starting material sourced exclusively...
Regulatory considerations for pharmaceutical excipient selection
The article discusses the role and importance of excipients in medicines, focusing on regulatory aspects...
le ultime news
09 Feb
Pharma expert discusses effort to standardize CMC quality information
06 Feb
US FDA proposes waiving GDUFA facility fees for domestic manufacturers
Computer Software Assurance for Production and Quality Management System Software
04 Feb
FDA, EMA officials encourage companies to pilot eCTD 4.0
03 Feb
China revises drug administration regulations to spur innovation, tighten oversight
02 Feb
USA - A Quality Tax for Foreign Drug Makers? The Links Between National Security, Trade Deals, and Drug Quality.
29 Gen
US FDA Announces PreCheck Implementation Roadmap
<<<6 7
